Gladstone Institutional Advisory’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$228K Buy
641
+62
+11% +$19.9K 0.01% 903
2026
Q2
$280K Buy
+579
New +$154K 0.01% 759

Other funds holding ALAB

Gladstone Institutional Advisory's ALAB Position: Q3 2026 in Review

Gladstone Institutional Advisory increased its Astera Labs (ALAB) stake by 11% in Q3 2026, buying an estimated $19.9K and bringing the position to 641 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #903.

Gladstone Institutional Advisory first reported a position in ALAB in Q2 2026 and has held it in 2 quarters since. The position peaked at $280K in Q2 2026. 804 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Gladstone Institutional Advisory held 641 shares of Astera Labs worth $228K as of Q3 2026.
  • Gladstone Institutional Advisory bought 62 Astera Labs shares in Q3 2026, an estimated $19.9K.
  • Astera Labs made up 0.01% of Gladstone Institutional Advisory's portfolio in Q3 2026, its #903 holding.
  • Gladstone Institutional Advisory first reported a position in Astera Labs in Q2 2026 and has held it in 2 quarters since.
  • Gladstone Institutional Advisory's Astera Labs position peaked at $280K in Q2 2026.
  • 804 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.